Early detection is the most important factor in a melanoma diagnosis—when discovered early, the survival rate is 99%. But it drops to 25% once it spreads distantly.
With DermTech, doctors use the Smart Sticker to see past the surface—deep within your skin’s genes—to find and detect disease earlier than ever before.
What does this mean? The Smart Sticker looks 10,000x closer to find genomic changes before they are even visible under a microscope.
How does it work? The DermTech Smart Sticker collects tissue from your skin’s surface easily, accurately, and painlessly. Then your doctor sends it to The DermTech Gene Lab where a patented scientific process analyzes the tissue to detect genomic changes associated with melanoma. Depending on the results, the mole may continue to be monitored or your doctor may biopsy according to the current standard of care.
Better yet? This revolutionary process can be ordered and directed by your doctor remotely through telehealth, allowing you the flexibility to maintain regular skin checks without an office visit.
Thanks to the DermTech Smart Sticker, doctors have another way to test for melanoma. It’s the step before the scalpel. Ask your doctor to DermTech it!
Find a DermTech Specialist near you.
DermTech now also offers Luminate, the world’s first skin test that identifies UV damage in your skin’s genes.
Luminate uses DermTech’s Smart Sticker technology to detect UV damage to your skin far before it shows up on the surface. With Luminate’s advanced genomic analysis and personalized information, you now have the tools to truly know your skin, and the power to take control of its care. Not only does Luminate indicate your actual level of UV damage at the DNA level, it gives you personalized, science-based recommendations on how to restore and repair that damage.
DermTech works with an independent network of board-certified physicians to support your at-home Luminate testing experience. A physician will review your Luminate survey responses and approve orders that meet the requirements for testing. A physician will also review your Luminate results when completed by the Gene Lab.
Visit www.LuminateDNA.com to reserve your Luminate test today and be one of the first to know your skin at the DNA level.
Location: United States, California, San Diego
Employees: 201-500
Phone: +1 858-450-4222
Total raised: $38M
Founded date: 1995
Investors 1
Date | Name | Website |
- | HLM Ventur... | hlmvp.com |
Funding Rounds 4
Date | Series | Amount | Investors | Deal News |
01.11.2017 | Series C | $10M | - | socaltech.... |
14.08.2015 | - | $20M | - | medcitynew... |
15.04.2015 | - | $2.4M | - | medcitynew... |
20.08.2013 | Series B | $5.6M | - | finsmes.co... |
Mentions in press and media 17
Date | Title | Description | Source |
13.07.2023 | Louisiana's melanoma rate is lower than the national average... | Skin cancer rates in Louisiana are lower than the national average, according to data the Centers fo... | axios.com/... |
18.05.2023 | Slone Partners Places Bret Christensen as President and CEO ... | “Bret Christensen is a strategic and visionary leader with more than 20 years of successful experien... | prweb.com/... |
16.11.2022 | Non-Invasive, Precision-Based Approaches for Diagnosis and T... | Michael D. Howell, Ph.D., Chief Scientific Officer of DermTech Inflammatory skin conditions such as... | hitconsult... |
07.04.2022 | Three Ways To Inspire Accountability For Organizational Succ... | John Dobak, M.D., is the CEO of DermTech. getty Organizational accountability defines a compan... | forbes.com... |
15.12.2021 | BioIQ and DermTech Enter into an Agreement to Add Non-invasi... | ATLANTA and LA JOLLA, Calif., Dec. 15, 2021 /PRNewswire/ -- BioIQ, Inc., ("BioIQ") an anal... | marketscre... |
09.11.2021 | Slone Partners Places L’Oréal USA Consumer Products Division... | “Her extensive strategic and operational experience and innovative spirit will be valuable additions... | prweb.com/... |
02.03.2020 | DermTech has announced it expects to raise $65 Million of fu... | - | connect.or... |
01.11.2017 | DermTech Raises $10M In Series C Funding | La Jolla-based molecular dermatology startup DermTech announced today that it has raised $10M in its... | socaltech.... |
04.02.2016 | Cocoon Networks invests £500 M in European tech startups | Chinese technology and investment group Cocoon Networks is launching a 500 million ($720 million) Lo... | itkey.medi... |
14.08.2015 | Making up for scrapped IPO, melanoma diagnostics company Der... | The company, founded in 1995, withdrew its IPO filing last November. As of June 30, 2014 it had book... | medcitynew... |
Show more